Dorzolamide: all 31 studies that test it
Page 1 of 1. Open to participants first (0), then studies with results posted, then the rest; newest registration first within each.
- Stop Retinal Ganglion Cell Dysfunction StudyTerminatedNCT02390284Phase 3Results posted
- The Effect of Glaucoma Drops on of the Duration of a Pure Intraocular Gas BubbleCompletedNCT01843920Not applicableResults posted
- Efficacy and Safety of Topically Applied Medical Therapy for the Treatment of Pediatric GlaucomaCompletedNCT01527682Phase 2Results posted
- Patient Preference Comparison of AZARGA Versus COSOPTCompletedNCT01340014Phase 4Results posted
- Effect of Topical Aqueous Suppressants on Intraocular Gas Duration Following Pars Plana VitrectomyCompletedNCT01257698Not applicableResults posted
- Intraocular Pressure and Ocular Perfusion Pressure of Cosopt in Normal Tension GlaucomaCompletedNCT01175902Not applicableResults posted
- Treatment of Cystoid Macular Edema in Patients With Retinal DegenerationCompletedNCT00716586Phase 4Results posted
- Circadian Rhythms of Aqueous Humor Dynamics in HumansCompletedNCT00572936Phase 2Results posted
- How Much Does Reduced Dosing of Latanoprost and Dorzolamide-timolol Affect Pressure?TerminatedNCT06369077Phase 4
- Dorzolamide+Timolol Multidose Preservative-free vs Dorzolamida+Timolol BAK Preserved Efficacy and SafetyCompletedNCT05857267Phase 4
- Augmented Macular Pigment-containing Nutraceutical and Central Visual FunctionWithdrawnNCT04676126Phase 4
- Choroidal Thickness and Its Correlations With Ocular Parameters in Primary Open-angle GlaucomaCompletedNCT03966560Phase 4
- KJ-TFC-004 Drug-drug Interaction StudyCompletedNCT02967614Phase 1
- Effectiveness and Safety of Timolol and Dorzolamide Loaded Contact LensesCompletedNCT02852057Phase 1
- 24-hour Efficacy and Ocular Surface With Talfuprost and Triple Combined TherapyCompletedNCT02802137Phase 4
- Pupillary Response After Glaucoma MedicationCompletedNCT02522039Not applicable
- Impact of Timolol/Dorzolamide Therapy on Autoregulation in Glaucoma PatientsCompletedNCT02053298Phase 4
- Safety and Efficacy of Triple Combination Therapy With Dorzolamide Hydrochloride / Brimonidine Tartrate / Timolol Ophthalmic Solution in Patients With Glaucoma or Ocular HypertensionWithdrawnNCT01284166Phase 3
- A Comparison of the Effect of Dorzolamide and Timolol on Optic Disk Blood Flow in Patients With Open Angle GlaucomaCompletedNCT00991822Phase 2/3
- 24-hr Intraocular Pressure Control With Dorzolamide/Timolol vs the Brimonidine/Timolol Fixed CombinationCompletedNCT00972257Phase 4
- The DIOXXACT Trial(Diurnal IOP and OBF Xalatan vs Xalatan And Cosopt Trial)CompletedNCT00957190Phase 4
- Equivalence Study of Dorzolamide 2% Eye Drops SolutionCompletedNCT00878917Phase 3
- Comparison of the Fixed Combinations of Brimonidine/Timolol and Dorzolamide/Timolol in Subjects With Open-Angle Glaucoma or Ocular HypertensionCompletedNCT00822081Phase 4
- Comparison of the Fixed Combinations of Brimonidine/Timolol and Dorzolamide/Timolol in Subjects With Open-Angle Glaucoma or Ocular HypertensionCompletedNCT00822055Phase 4
- Comparison of Brimonidine Purite, Dorzolamide, and Brinzolamide as Adjunctive Therapy to Prostaglandin AnalogsCompletedNCT00675207Phase 4
- Pharmacological Intervention in Diabetic RetinopathyCompletedNCT00619034Not applicable
- Patient Preference StudyCompletedNCT00576342Phase 3
- A Study to Evaluate the Effectiveness of Cosopt® as First Line Therapy (MK-0507A-153)CompletedNCT00546286Phase 3
- 24-hour Study of Dorzolamide/Timolol and Latanoprost/Timolol Fixed CombinationsCompletedNCT00397241Phase 4
- Effects of Common Topical Glaucoma Therapy on Optic Nerve Head Blood Flow Autoregulation During Increased Arterial Blood Pressure and Artificially Elevated Intraocular Pressure in Healthy HumansWithdrawnNCT00275756Not applicable
- Ocular Blood Flow in Early Glaucoma Patients Before and After Treatment With DorzolamideStatus unknownNCT00152932Not applicable